Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
October 23, 2026 22.12
October 22, 2026 21.94
October 21, 2026 23.02
October 20, 2026 21.49
October 19, 2026 23.97
October 16, 2026 27.61
October 15, 2026 28.51
October 14, 2026 27.52
October 13, 2026 31.38
October 12, 2026 31.29
October 09, 2026 32.91
October 08, 2026 32.19
October 07, 2026 34.35
October 06, 2026 36.60
October 05, 2026 36.24
October 02, 2026 35.39
October 01, 2026 36.42
September 30, 2026 39.84
September 29, 2026 42.98
September 28, 2026 45.86
September 25, 2026 62.50
September 24, 2026 66.55
September 23, 2026 66.55
September 22, 2026 64.57
September 21, 2026 59.53
Date Value
September 18, 2026 57.10
September 17, 2026 60.43
September 16, 2026 58.36
September 15, 2026 63.22
September 14, 2026 62.05
September 11, 2026 62.44
September 10, 2026 59.71
September 09, 2026 72.12
September 08, 2026 75.20
September 04, 2026 91.87
September 03, 2026 72.23
September 02, 2026 73.88
September 01, 2026 75.56
August 31, 2026 76.74
August 28, 2026 75.61
August 27, 2026 78.94
August 26, 2026 73.56
August 25, 2026 68.76
August 24, 2026 67.44
August 21, 2026 67.68
August 20, 2026 63.02
August 19, 2026 71.58
August 18, 2026 68.70
August 17, 2026 77.70
August 14, 2026 81.49

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
BioLineRx Ltd. 0.6472
XTL Biopharmaceuticals Ltd. --
Kamada Ltd. 1.663
Can-Fite BioPharma Ltd. 1.292
Eocene Ltd. 0.2382

Price to Book Value Related Metrics

Price 2.46
Market Cap 80.09M